Paricalcitol for secondary hyperparathyroidism in renal transplantation.
about
Mineral and bone disorder after kidney transplantationInterplay of vitamin D, erythropoiesis, and the renin-angiotensin systemImpact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patientsPhosphate and FGF-23 homeostasis after kidney transplantation.Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.Current evidence on vitamin D deficiency and kidney transplant: What's new?CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.Bone Disease after Kidney Transplantation.Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: A Randomized Controlled Trial.Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease : A meta-analysis.Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.Vitamin D and Uterine Fibroids-Review of the Literature and Novel ConceptsParicalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
P2860
Q26771398-689C5BA4-DEFE-4371-B27D-3053C39A7B69Q26822500-3AD91A4B-48E0-4655-8CE0-6B0880138476Q33783035-581E577E-37E2-4007-92B5-047009F5CEFDQ38594874-9F89ABB0-9C16-400E-B976-E86B0F3CB1F8Q38691202-ABE7D229-35F7-490D-850A-F48315B777D3Q38803449-AD457656-2CF7-4876-916D-A132AADFEEEBQ39172404-36C5D10A-3A97-44D3-8216-1B2F36D629F2Q39247900-7123717C-D933-43E5-B037-A8747C87CCAAQ39447041-67A452D3-B0A8-4BE1-B489-605119811E27Q39970839-20E6A745-5970-433D-9BA9-D8E57A198D36Q40853318-A0DCB339-1D66-4D62-A2BE-64BECFCE363EQ48242270-71CB97C6-D9FA-426A-B103-88CA83C2D9DCQ49449891-FFA69C77-E393-48DB-91CB-9EBB1027AD30Q51823258-22009F65-D3AF-460D-8466-754C7368F54AQ53412995-49E52991-D0E3-49CD-9B48-21AEF02DCF49Q57176044-F542ED38-408B-4A73-A2C8-641A0A8F3583Q58721207-0230AD03-9F9C-4A57-8E3F-7FF2F5A135A0
P2860
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@ast
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@en
type
label
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@ast
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@en
prefLabel
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@ast
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@en
P2093
P2860
P50
P356
P1476
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
@en
P2093
Alessandro Villa
Antonio Cannata
Claudia Ferrer-Siles
Davide Martinetti
Eliana Gotti
Flavio Gaspari
Jorge Reyes Loaeza
Maria Rosa Caruso
Norberto Perico
Silvia Prandini
P2860
P304
P356
10.1681/ASN.2013111185
P50
P577
2014-09-05T00:00:00Z